⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENSC News
Ensysce Biosciences, Inc. Common Stock
Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans
accessnewswire.com
ENSC
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
accessnewswire.com
ENSC
Form 8-K
sec.gov
ENSCW
ENSC
Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength
globenewswire.com
RXT
PLTR
ENSC
Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength
globenewswire.com
RXT
PLTR
ENSC
Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value
accessnewswire.com
ENSC
Ensysce Biosciences Invited to Participate in Upcoming Scientific and Industry Events
accessnewswire.com
ENSC
Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain
accessnewswire.com
ENSC
Ensysce Biosciences Expands Global Opioid Patent Portfolio
accessnewswire.com
ENSC
Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection
accessnewswire.com
ENSC